Intrexon reported $0 in Ordinary Share Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Amgen AMGN:US $ 31989M 112M
Anika Therapeutics ANIK:US $ 0.14M 0M
AstraZeneca AZN:LN 387M 59M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Bristol Myers Squibb BMY:US $ 292M 0M
Chemocentryx CCXI:US $ 0.07M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Flexion Therapeutics FLXN:US $ 50K 0
GlaxoSmithKline GSK:LN 1347M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Intrexon XON:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Macrogenics MGNX:US $ 0.61M 0.01M
Mannkind MNKD:US $ 2.5M 0.01M
Novartis NOVN:VX SF 901M 12M
Peregrine Pharmaceuticals PPHM:US $ 0.06M 0M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.46M 0M
Veracyte VCYT:US $ 0.07M 0M
Xencor XNCR:US $ 0.58M 0M
YTE INCY:US $ 0.22M 0M
Ziopharm Oncology ZIOP:US $ 0.22M 0M